BCTX logo

BCTX
BriaCell Therapeutics Corp

10,293
Mkt Cap
$25.3M
Volume
491,982.00
52W High
$36.90
52W Low
$2.98
PE Ratio
-0.13
BCTX Fundamentals
Price
$3.49
Prev Close
$3.72
Open
$3.45
50D MA
$4.10
Beta
1.11
Avg. Volume
155,528.13
EPS (Annual)
-$62.19
P/B
0.82
Rev/Employee
$0.00
$15.32
Loading...
Loading...

About

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17

Frequently Asked Questions

What is Market Cap of BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the 52-week high for BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the 52-week low for BriaCell Therapeutics Corp - Ordinary Shares - New?
What is BriaCell Therapeutics Corp - Ordinary Shares - New stock price today?
What was BriaCell Therapeutics Corp - Ordinary Shares - New stock price yesterday?
What is the PE ratio of BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the Price-to-Book ratio of BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the 50-day moving average of BriaCell Therapeutics Corp - Ordinary Shares - New?
How many employees does BriaCell Therapeutics Corp - Ordinary Shares - New have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available